Showing results (121-130 of 330) with videos related to

Sort By:
Pageof 33
European Journal of Gastroenterology & Hepatology|June 2, 2020
Early detection of hepatocellular carcinoma in patients with diabetes mellitusKazuhiro Nouso, Yoshie Furubayashi, Shohei Shiota, et al.
Diabetes, Obesity & Metabolism|September 3, 2024
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease: A prospective, multicentre, observational studyTaeang Arai, Masanori Atsukawa, Akihito Tsubota, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 21, 2025
Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination TherapyHironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, et al.
Journal of Gastroenterology|February 23, 2017
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide surveyHienori Toyoda, Toshifumi Tada, Philip J Johnson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 7, 2005
Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinomaToshifumi Tada, Takashi Kumada, Hidenori Toyoda, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 29, 2025
Impact of intrahepatic lesions on lesion-specific response rates in patients with hepatocellular carcinoma treated with lenvatinib or immune checkpoint inhibitorsMasaki Omori, Shohei Komatsu, Toshifumi Tada, et al.
Liver Cancer|January 14, 2021
EZ-ALBI Score for Predicting Hepatocellular Carcinoma PrognosisKazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 20, 2017
A better method for assessment of hepatic function in hepatocellular carcinoma patients treated with radiofrequency ablation: Usefulness of albumin-bilirubin gradeAtsushi Hiraoka, Takashi Kumada, Masashi Hirooka, et al.
World Journal of Surgery|March 12, 2026
Impact of Borderline Resectable Criteria on Hepatocellular Carcinoma Treatment From the Perspective of Tumor BurdenShohei Komatsu, Toshifumi Tada, Nobuaki Ishihara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 3, 2020
Attenuation imaging based on ultrasound technology for assessment of hepatic steatosis: A comparison with magnetic resonance imaging-determined proton density fat fractionToshifumi Tada, Takashi Kumada, Hidenori Toyoda, et al.
Pageof 33